The US Supreme Court has agreed to hear the appeal filed by pharmaceutical company Danco on an emergency stay issued by a lower court on its sale of mifepristone, also called RU-486, and use of it without a prescription. Danco argued that the emergency stay was “an unprecedented judicial assault” on the regulatory process that…